Table 3.
Cohort | n | Total Prescription Dose (Gy)
|
PTVi (cm3)
|
PTVi Dose (Gy)
|
PTVboost (cm3)
|
PTVboost (Gy)
|
---|---|---|---|---|---|---|
Median (Range) | Median±SD | Median (Range) | Median±SD | Median (range) | ||
All | 41 | 54 (45–64) | 927.6±440.1 | 46 (41.4–60.4) | 371.8±258.8 | 14 (4–18) |
| ||||||
Locally advanced | 24 | 59.4 (45–64) | 961.2.5±483.1 | 46 (41.4–60.4) | 354.7±238.8 | 11 (4–18) |
| ||||||
Adjuvant | 17 | 54 (45–64) | 868.9±383.6 | 46 (45–50.4) | 436.1±304.5 | 8 (4–18) |
| ||||||
R0 resection | 6 | 52.2 (45–60) | 778.9±312.2 | 48 (45–50.4) | 532.2±136.5 | 8 (6–14) |
| ||||||
R1 resection | 11 | 54 (50–64) | 1028.2±418.8 | 46 (46–50.4) | 340.8±364.4 | 8 (4–18) |